相关实验视频

Updated: Jul 23, 2026

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
16:24

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells

Published on: February 21, 2014

20.6K

在三阴性乳腺癌中识别和分析与代谢重编程相关的基因

Husheng Kong1, Mengyuan Pan1, Li Sun2,3

  • 1The Affiliated Xuzhou Clinical College of Xuzhou Medical University, Xuzhou, China.

Clinical and experimental medicine
|October 25, 2025
PubMed
概括

研究人员确定了四个关键基因 (CLEC7A,IRS1,RSPO3,ALB) 与三阴性乳腺癌 (TNBC) 的代谢重编程有关. 这些基因显示出作为改善TNBC诊断和治疗的新生物标志物的潜力.

关键词:
生物标志物 生物标志物免疫系统的透.免疫组织化学 免疫组织化学机器学习是机器学习.代谢重编程是一种代谢重编程.三阴性乳腺癌是三阴性乳腺癌.

更多相关视频

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer10:36

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer

Published on: March 17, 2016

10.9K
Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

18.8K

相关概念视频

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...